Effects of paracetamol and stress on morphology and gene expression in the rat hippocampus
https://doi.org/10.47470/0016-9900-2026-105-3-314-320
EDN: rvqfli
Abstract
Introduction. Chronic stress and paracetamol exposure are among the most relevant factors affecting neurochemical and molecular processes in the brain in modern humans. Excessive activation of inflammatory and oxidative pathways during chronic psychosocial stress can lead to a decrease in the expression of neuroprotective and antioxidant genes, exacerbating the neurotoxic effects of drugs such as paracetamol.
Objective. To assess the effect of chronic unpredictable stress and oral administration of paracetamol, as well as their combined effect on the morphological state of the brain and on the expression of genes of the antioxidant system and neurotrophic factor in the hippocampus in rats.
Materials and methods. The experiment was conducted on forty eight rats (males and females in equal numbers), divided into four groups: control, chronic stress, paracetamol, combined exposure to stress and paracetamol. A complex of various stressors was used to model chronic stress. Paracetamol was administered orally at a dose of 1000 mg/kg. The morphological state of the hippocampus was assessed histologically, gene expression - by quantitative real-time PCR. Statistical analysis included bootstrapping and correction for multiple comparisons using the Holm-Bonferroni method.
Results. Macroscopic and histological examination of the rat brain showed the preservation of the normal anatomical structure and integrity of the hippocampal tissues in all groups. Statistical analysis of gene expression showed animals treated with paracetamol (groups III and IV) to show a significant decrease in the mRNA levels in the Sod1 and Bdnf genes in the hippocampus compared to the control and the group exposed to stress only (group II). The expression level of Sod1 and Bdnf was significantly lower in both males and females in these groups (p = 0.001). For the Hmox1 gene, a significant decrease in expression was found only in males in the paracetamol-treated group, while no changes were noted in females.
Limitations. Laboratory animals of the same biological species were used for the experiment, and the toxicant was used in only one concentration.
Conclusion. Thus, paracetamol, both in isolated use and in combination with chronic stress, has a more pronounced inhibitory effect on the expression of key genes of antioxidant protection and neurotrophic support than stress alone.
Compliance with ethical standards. Date of the meeting of the bioethics commission of theUfa Research Institute of Occupational Medicine and Human Ecology dated 02/08/2024 No. 01–02. Throughout the study, the animals were kept in standard conditions with 12-hour artificial lighting during the daytime, a relatively constant level of humidity (30–70%) and an air temperature of 20–25 °C. All animal manipulations were carried out in strict compliance with the rules prescribed in the basic regulatory documents, including the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Strasbourg, 1986) and the Helsinki Declaration on the Humane Treatment of Animals.
Contributions:
Gizatullina A.A. – concept and study design, material collection and processing, statistical analysis, manuscript writing;
Valova Ya.V. – material collection and processing, statistical analysis;
Mukhamadieva G.F. – editing;
Karimov D.O. – concept and study design, statistical analysis;
Karimov D.D. – material collection and processing;
Ryabova Yu.V. – material collection and processing;
Khusnutdinova N.Yu. – material collection and processing;
Khmel A.O. – material collection and processing.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.
Conflict of interest. The authors declare no conflict of interest.
Funding. Industry research program of Rospotrebnadzor for 2021–2025 “Scientific substantiation of the national system for ensuring sanitary and epidemiological welfare, managing health risks and improving the quality of life of the population of Russia”, on the topic: 6.9.1.2 “Study of the impact of chemical production factors under conditions of chronic stress” No. NIOKTR I124021200153-3.
Received: April 30, 2025 / Revised: July 9, 2025 / Accepted: October 15, 2025 / Published: April 17, 2026
About the Authors
Alina A. GizatullinaRussian Federation
Junior researcher, Laboratory of genetics, Department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation
e-mail: alinagisa@yandex.ru
Yana V. Valova
Russian Federation
PhD (Biology), Laboratory of genetics, department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation
e-mail: Q.juk@yandex.ru
Guzel F. Mukhammadieva
Russian Federation
PhD (Biology), senior researcher, Genetics laboratory, Department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology
e-mail: ufniimt@mail.ru
Denis O. Karimov
Russian Federation
PhD (Medicine), head, Department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation; N.A. Semashko National Research Institute of Public Health, Moscow, 105064, Russian Federation
e-mail: karimovdo@gmail.com
Denis D. Karimov
Russian Federation
PhD (Biology), Head, Laboratory of genetics, department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation
e-mail: karriden@gmail.com
Yulia V. Ryabova
Russian Federation
PhD (Medicine), head, Laboratory of toxicology, department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation
e-mail: ryabovaiuvl@gmail.com
Nadezhda Yu. Khusnutdinova
Russian Federation
Researcher, Toxicology laboratory, Department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation
e-mail: h-n-yu@yandex.ru
Alexandra O. Khmel
Russian Federation
Junior researcher, Toxicology laboratory, Department of toxicology and genetics with experimental clinic of laboratory animals, Ufa Research Institute of Occupational Health and Human Ecology, Ufa, Russian Federation
e-mail: khmel.al01@gmail.com
References
1. Miller A., Raison C. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 2016; 16(1): 22–34. https://doi.org/10.1038/nri.2015.5
2. Hinz B., Brune K. Paracetamol and the cyclooxygenase enzymes. In: Hinz B., Brune K., eds. Handbook of Experimental Pharmacology. Volume 214. Springer; 2012: 121–38. https://doi.org/10.1007/978-3-642-23032-2_6
3. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 2004; 10(Suppl.): S18–25. https://doi.org/10.1038/nrn1434
4. Shukla V., Mishra S.K., Pant H.C. Oxidative stress in neurodegeneration. Adv. Pharmacol. Sci. 2011; 2011: 572634. https://doi.org/10.1155/2011/572634
5. Houldsworth A. Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants. Brain Commun. 2024; 6(1): fcad356. https://doi.org/10.1093/braincomms/fcad356
6. Sienes Bailo P., Llorente Martín E., Calmarza P., Montolio Breva S., Bravo Gómez A., Pozo Giráldez A., et al. The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies. Adv. Lab. Med. 2022; 3(4): 342–60. https://doi.org/10.1515/almed-2022-0111
7. Conrad C.D., Ortiz J.B., Judd J.M. Chronic stress and hippocampal dendritic complexity: methodical and functional considerations. Physiol. Behav. 2017; 178: 66–81. https://doi.org/10.1016/j.physbeh.2016.11.017
8. Mineur Y.S., Mose T.N., Vanopdenbosch L., Etherington I.M., Ogbejesi C., Islam A., et al. Hippocampal acetylcholine modulates stress-related behaviors independent of specific cholinergic inputs. Mol. Psychiatry. 2022; 27(3): 1829–38. https://doi.org/10.1038/s41380-021-01404-7
9. Karakilic A., Kizildag S., Yuce Z., Celik Y.S., Kandis S., Bozan H.R., et al. Repeated acetaminophen administration damaged hippocampal tissue but did not affect prefrontal cortex or anxiety behaviors. Acta Neurobiol. Exp. (Wars). 2022; 82(2): 170–8. https://doi.org/10.55782/ane-2022-015
10. Wu D., Hu Q., Wang Y., Jin M., Tao Z., Wan J. Identification of HMOX1 as a critical ferroptosis-related gene in atherosclerosis. Front. Cardiovasc. Med. 2022; 9: 833642. https://doi.org/10.3389/fcvm.2022.833642
11. Eleutherio E.C.A., Silva Magalhães R.S., de Araújo Brasil A., Monteiro Neto J.R., de Holanda Paranhos L. SOD1, more than just an antioxidant. Arch. Biochem. Biophys. 2021; 697: 108701. https://doi.org/10.1016/j.abb.2020.108701
12. Zhivkovich M., Ermolaeva E.V., Soboleva A.V., Samoilova E.M., Chudakova D.A., Baklaushev V.P. Brain neurotrophic factor BDNF: new data, functions and questions. Geny i kletki. 2024; 19(1): 61–84. https://doi.org/10.17816/gc623163 https://elibrary.ru/pscysm (in Russian)
13. Ji Y., Luo J., Zeng J., Fang Y., Liu R., Luan F., et al. Xiaoyao pills ameliorate depression-like behaviors and oxidative stress induced by olfactory bulbectomy in rats via activation of the PIK3CA-AKT1-NFE2L2/BDNF signaling pathway. Front. Pharmacol. 2021; 12: 643456. https://doi.org/10.3389/fphar.2021.643456
14. Takei Y., Amagase Y., Sugiyama A. Peritoneal signaling improves hippocampal BDNF expression in aged mice. Aging (Albany NY). 2023; 15(14): 6625–6. https://doi.org/10.18632/aging.204919
15. Timasheva G.V., Baygildin S.S., Bakirov A.B., Repina E.F., Karimov D.O., Khusnutdinova N.Yu., et al. Morphological changes in the liver of experimental animals in the early stages after correction of exposure to high doses of paracetamol. Toksikologicheskii vestnik. 2022; 30(1): 21–8. https://doi.org/10.47470/0869-7922-2022-30-1-21-28 https://elibrary.ru/lkoafi (in Russian)
16. Ghorbanzadeh B., Azizolahi B., Masoudipur F., Boroun A., Azizi M., Oroojan A.A., et al. Low doses of acetaminophen produce antidepressive-like effects through the opioid system in mice. Behav. Brain Res. 2024; 469: 115065. https://doi.org/10.1016/j.bbr.2024.115065
17. Daugel-Dauge N.O., Zhanataev A.K., Durnev A.D. In vivo genotoxicity assessment of paracetamol and its combination with verapamil. Eksperimental’naya i klinicheskaya farmakologiya. 2017; 80(4): 23–7. https://doi.org/10.30906/0869-2092-2017-80-4-23-27 https://elibrary.ru/ymjfmr (in Russian)
18. Vlasova Yu.A., Golovanova N.E., Beishebaeva Ch.R., Zagorodnikova K.A., Sokolova M.N., Dadali V.A., et al. Study of neurotoxicity of paracetamol and its metabolite NAPQI (short message). Laboratornye zhivotnye dlya nauchnykh issledovanii. 2021; (4): 82–6. https://doi.org/10.29296/2618723X-2021-04-09 https://elibrary.ru/vmnssf (in Russian)
19. Gervin K., Nordeng H., Ystrom E., Reichborn-Kjennerud T., Lyle R. Long-term prenatal exposure to paracetamol is associated with DNA methylation differences in children diagnosed with ADHD. Clin. Epigenet. 2017; 9: 77. https://doi.org/10.1186/s13148-017-0376-9
20. Matisz C.E., Badenhorst C.A., Gruber A.J. Chronic unpredictable stress shifts rat behavior from exploration to exploitation. Stress. 2021; 24(5): 635–44. https://doi.org/10.1080/10253890.2021.1947235
21. Akhmadiev P.A., Lastochkin A.A., Tazetdinov A.M., Takhirova Z.R., Khismatullina Z.R. Spatial learning of DAT-HET rat line in an eight-arm radial maze. Laboratornye zhivotnye dlya nauchnykh issledovanii. 2024; (3): 51–8. https://doi.org/10.57034/2618723X-2024-03-04 https://elibrary.ru/jsoahr (in Russian)
22. Belyakov V.I., Inyushkina E.M., Gromova D.S., Inyushkin A.N. Laboratory Rats: Housing, Breeding and Bioethical Aspects of Use in Behavioral Physiology Experiments [Laboratornye krysy: soderzhanie, razvedenie i bioeticheskie aspekty ispol’zovaniya v eksperimentakh po fiziologii povedeniya]. Samara; 2021. https://elibrary.ru/mpwuif (in Russian)
23. Shikh E.V., Khaytovich E.D., Perkov A.V. Clinical and pharmacological approaches to the choice of a drug for a tension-type headache relief. Terapevticheskii arkhiv. 2021; 93(8): 862–8. https://doi.org/10.26442/00403660.2021.08.200920 https://elibrary.ru/ijmmzb (in Russian)
24. Livak J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001; 25(4): 402–8. https://doi.org/10.1006/meth.2001.1262
25. Simon M.S., Schiweck C., Arteaga-Henríquez G., Poletti S., Haarman B.C.M., Dik W.A., et al. Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021; 111: 110391. https://doi.org/10.1016/j.pnpbp.2021.110391
26. Dunn L.L., Kong S.M.Y., Tumanov S., Chen W., Cantley J., Ayer A., et al. Hmox1 (Heme Oxygenase-1) protects against ischemia-mediated injury via stabilization of HIF-1α (Hypoxia-inducible factor-1α). Arterioscler. Thromb. Vasc. Biol. 2021; 41(1): 317–30. https://doi.org/10.1161/ATVBAHA.120.315393
27. Ofosu-Boateng M., Shaik F., Choi S., Ekuban F.A., Gebreyesus L.H., Twum E., et al. High-fat diet-induced obesity promotes inflammation, oxidative stress, and hepatotoxicity in female FVB/N mice. Biofactors. 2024; 50(3): 572–91. https://doi.org/10.1002/biof.2028
28. Mukhammadieva G.F., Bakirov A.B., Karimov D.O., Valova Ya.V., Ziatdinova M.M., Kudoyarov E.R., et al. Expression of the Sod1 gene under conditions of experimental ethanol intoxication and administration of hepatoprotective drugs. Eksperimental‘naya i klinicheskaya gastroenterologiya. 2021; (10): 132–7. https://doi.org/10.31146/1682-8658-ecg-194-10-132-137 https://elibrary.ru/kuqxnb (in Russian)
29. Karimov D.O., Mukhammadiyeva G.F., Bakirov A.B., Ziatdinova M.M., Valova Ya.V., Kudoyarov E.R., et al. Dynamics of superoxide dismutase-1 gene expression in different types of drug correction of toxic disorders in the liver. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2022; 101(1): 83–6. https://doi.org/10.47470/0016-9900-2022-101-1-83-86 https://elibrary.ru/eaknjs (in Russian)
30. Mukhammadieva G.F., Karimov D.O., Bakirov A.B., Valova Ya.V., Ziatdinova M.M., Repina E.F., et al. Changes in Sod1 gene expression in rat liver exposed to toxicants. Meditsina truda i ehkologiya cheloveka. 2020; (3): 108–13. https://doi.org/10.24412/2411-3794-2020-10314 https://elibrary.ru/cwsmkc (in Russian)
31. Shalaginova I.G., Zachepilo T.G., Dyuzhikova N.A. The effect of prolonged emotional and pain stress on the expression of the bdnf gene in the brain of rats with contrast excitability of the nervous system. Meditsinskii akademicheskii zhurnal. 2023; 23(1): 67–74. https://doi.org/10.17816/MAJ119980 https://elibrary.ru/hmofzw (in Russian)
32. Jiang Z., Zhu Z., Zhao M., Wang W., Li H., Liu D., et al. H3K9me2 regulation of BDNF expression in the hippocampus and medial prefrontal cortex is involved in the depressive-like phenotype induced by maternal separation in male rats. Psychopharmacology (Berl.). 2021; 238(10): 2801–13. https://doi.org/10.1007/s00213-021-05896-7
33. Zobnin Yu.V. Paracetamol Poisoning: Clinic, Diagnosis, Treatment [Otravlenie paratsetamolom: klinika, diagnostika, lechenie]. Irkutsk; 2002. (in Russian)
34. McEwen B.S. Neurobiological and systemic effects of chronic stress. Chronic Stress (Thousand Oaks). 2017; 1: 2470547017692328. https://doi.org/10.1177/2470547017692328
Review
For citations:
Gizatullina A.A., Valova Ya.V., Mukhammadieva G.F., Karimov D.O., Karimov D.D., Ryabova Yu.V., Khusnutdinova N.Yu., Khmel A.O. Effects of paracetamol and stress on morphology and gene expression in the rat hippocampus. Hygiene and Sanitation. 2026;105(3):314-320. (In Russ.) https://doi.org/10.47470/0016-9900-2026-105-3-314-320. EDN: rvqfli
JATS XML
































